Zomedica (ZOM) Announces TRUFORMA™ Commercialization Date

Zomedica Corp. (AMEX: ZOM) has revealed today the date of the marketing of TRUFORMA™. The drug manufacturer disclosed that it is planning to commence the launch of the TRUFORMA™ point-of-care diagnostic platform on March 30, 2021.

From the last few months, the company has strived to bring the diagnostic platform to the market, and finally, it got a chance to market its diagnostic platform. The TRUFORMA platform of the company is being developed by using the Bulk Acoustic wave (BAW) technology which is developed by Qorvo. This technology is not only embedded in mobile phones but also in advanced radar and communications systems around the globe.

The diagnostic platform of the company is secured by 70 issued and pending patents. Zomedica Corp believed that this platform of the company would be very useful for the detection and diagnosis of diseases. TRUFORMA is the first platform that uses BAW technology to help in diagnosis.

Shares of Zomedica Corp. (AMEX: ZOM) soared 57.87% at $0.1257 during the pre-market trading session of Friday. It has recorded a trading volume of 19.46 million as compared to the average volume of 23.41 million. In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $0.06 and a high of $0.50. Zomedica market capitalization has remained high, hitting $47.76 million at the time of writing.

The company is currently involved in the development of five assays including two panels one each to identify thyroid and adrenal disease. Zomedica has also finalized authentication for canine and feline TSH, canine and feline tT4, canine fT4 and canine cortisol assays, and certification efforts are being made for all of these tests.

The drug manufacturer is currently working on the building of its sales organization for the market launch of its product. Earlier, it has been disclosed that this organization will consist of direct sales representatives, professional service veterinarians, distributors, distributor support representatives. Zomedica will fully provide support for the new organization.

Related Articles

Why Ayro (NASDAQ: AYRO) Stock Is Crashing Today?

Shares of Ayro Inc. (NASDAQ: AYRO) plummeted by 23.49% during the trading session on Tuesday. The firm has disclosed that it has completed the...

Amazon (NASDAQ: AMZN) Join Hands With Federal Watchdog To Stop Counterfeits

Amazon.com, Inc. (NASDAQ: AMZN) has disclosed today that it has teamed up with the National Intellectual Property Rights Coordination Center (IPR Center), a counterfeit...

Goldfield Corporation (GV) Signs Merger Agreement With First Reserve

The Goldfield Corporation (AMEX: GV) has signed a merger agreement with First Reserve. The merger agreement has allowed the affiliate of First Reserve to...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Why Ayro (NASDAQ: AYRO) Stock Is Crashing Today?

Shares of Ayro Inc. (NASDAQ: AYRO) plummeted by 23.49% during the trading session on Tuesday. The firm has disclosed that it has completed the...

Amazon (NASDAQ: AMZN) Join Hands With Federal Watchdog To Stop Counterfeits

Amazon.com, Inc. (NASDAQ: AMZN) has disclosed today that it has teamed up with the National Intellectual Property Rights Coordination Center (IPR Center), a counterfeit...

Goldfield Corporation (GV) Signs Merger Agreement With First Reserve

The Goldfield Corporation (AMEX: GV) has signed a merger agreement with First Reserve. The merger agreement has allowed the affiliate of First Reserve to...

Here’s Why Sundial Growers (NASDAQ: SNDL) Stock Soaring Today?

Shares of Sundial Growers Inc. (NASDAQ: SNDL) has surged 34.55% with heavy volume during the trading session of Tuesday. It has recorded a trading...

Siyata Mobile (NASDAQ: SYTA) Announces Distribution Agreement With pei tel

Siyata Mobile Inc. (NASDAQ: SYTA) announced it has entered into a distribution agreement with pei tel Communications GmbH, a distributor based in Germany, for...